Search This Blog

Wednesday, October 28, 2026

Chemed beats, now expects full-year 2026 adjusted EPS at or slightly above high end of prior guidance.

 

Chemed Corp reports fiscal Q3 2026 results with non-GAAP EPS $6.75 (+28% YoY) and revenue $690.9M (+11% YoY), beats EPS and revenue estimates

  • Now expects full-year 2026 adjusted EPS at or slightly above the high end of prior guidance.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)